STOCK MARKET BSE NSE

EU starts evaluation for J&J Covid vaccine booster 

Two other booster shots with vaccines made by Pfizer/Biontech and Moderna have already been approved for use in the EU.

Published: 22nd November 2021 08:12 PM  |   Last Updated: 22nd November 2021 08:12 PM   |  A+A-

Johnson and Johnson vaccine

Johnson and Johnson vaccine. (Photo | AP)

By AFP

THE HAGUE: The EU's drug watchdog on Monday, November 22, 2021, said it was evaluating an application by Johnson & Johnson for its Covid vaccine booster shot to be used on people aged 18 and over in the bloc.

If approved, the booster will be the third in the 27-nation European Union for adults and will be given at least two months after a first single-shot dose.

"EMA's human medicines committee (CHMP) will carry out an accelerated assessment of data submitted by the company that markets the vaccine," the European Medicines Agency said, adding an outcome was "expected within weeks."

The data assessed by the Amsterdam-based EMA will include results from more than 14,000 adults who have received a second dose of the Covid-19 Vaccine Janssen or a placebo, the agency said.

Two other booster shots with vaccines made by Pfizer/Biontech and Moderna have already been approved for use in the EU.

The regulator has also currently approved four vaccines for use: Pfizer and Moderna, which use messenger RNA technology, and AstraZeneca and Johnson & Johnson, which use viral vector technology.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

edexworks
flipboard facebook twitter whatsapp